Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Aug 16, 2022 19:10
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Aug 16, 2022 19:08
Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Aug 9, 2022 19:07
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Aug 9, 2022 19:00
Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Jul 19, 2022 19:28
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Jul 19, 2022 19:13
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Jul 2, 2022 04:11
Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Jul 2, 2022 04:01
Turning Point Therapeutics | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9
Jun 18, 2022 04:46
Turning Point Therapeutics | SC TO-T: Third party tender offer statement
Jun 18, 2022 04:42
Turning Point Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer
Jun 4, 2022 05:18
Turning Point Therapeutics | SC TO-C: Written communication relating to an issuer or third party tender offer
Jun 4, 2022 05:15
Turning Point Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer
Jun 3, 2022 21:05
No Data
No Data